Glucose, insulin and potassium (GIK) during reperfusion mediates improved myocardial bioenergetics

Resuscitation

Volumn 55, Issue 3, 2002, Pages 329-336

  Angelos, Mark G ^a   Murray, Holt N ^a   Gorsline, Robert T ^a   Klawitter, Paul F ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Glucose; Heart arrest; Insulin; Ischemia; Myocardial dysfunction; Reperfusion

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; BICARBONATE; CREATINE PHOSPHATE; GLUCOSE; INOSINE; INSULIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OCTANOIC ACID; POTASSIUM;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; CONTROLLED STUDY; DRUG EFFECT; HEART CONTRACTION; HEART DISEASE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HEART PERFUSION; ISCHEMIA; MALE; NONHUMAN; PRESSURE; PRIORITY JOURNAL; RAT; RESUSCITATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; DISEASE MODELS, ANIMAL; GLUCOSE; INSULIN; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036893074     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(02)00215-0     Document Type: Article

References (35)

1. Fath-Ordoubadi F., Beatt K.J. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 96:1997;1152-1156.
2. Diaz R., Paolasso E.A., Piegas L.S., Tajer C.D., Moreno M.G., Corvalan R., Isea J.E., Romero G. Metabolic modulation of acute myocardial infarction. The ECLA glucose-insulin-potassium pilot trial. Circulation. 98:1998;2227-2234.
3. Svedjeholm R., Hakanson E., Szabo Z. Metabolic intervention for the ischemic and post-ischemic heart. Wien. Klin. Wochenschr. 111/113:1999;501-511.
4. Lazar H.L. Enhanced preservation of acutely ischemic myocardium and improved clinical outcomes using glucose-insulin-potassium (GIK) solutions. Am. J. Cardiol. 80:1997;90A-93A.
5. Taegtmeyer H., Goodwin G.W., Doenst T., Frazier O.H. Substrate metabolism as a determinant for post-ischemic functional recovery of the heart. Am. J. Cardiol. 80:1997;3A-10A.
6. + channels in isolated guinea pig cardiac myocytes. Science. 238:1987;67-69.
7. Schaefer S., Prussel E., Carr L.J. Requirement of glycolytic substrate for metabolic recovery during moderate low flow ischemia. J. Mol. Cell. Cardiol. 27:1995;2167-2176.
8. ++ overload in reperfused ischemic myocardium. Annu. Rev. Physiol. 52:1990;543-559.
9. Jeremy R.W., Koretsune Y., Marban E., Becker L.C. Relation between glycolysis and calcium homeostasis in postischemic myocardium. Circ. Res. 70:1992;1180-1190.
10. Angelos M.G., Griffith R.F., Beckley P.D., Rath D.P., Little C.M. Myocardial metabolic changes during reperfusion of ventricular fibrillation: a 31P NMR study in swine. Crit. Care Med. 23:1995;733-739.
11. Bolli R., Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol. Rev. 79:1999;609-634.
12. Deantonio H.J., Kaul S., Lerman B.B. Reversible myocardial depression in survivors of cardiac arrest. Pacing Clin. Electrophysiol. 13:1990;982-985.
13. Tang W., Weil M.H., Sun S., Gazmuri R.J., Bisera J. Progressive myocardial dysfunction after cardiac resuscitation. Crit. Care Med. 21:1993;1046-1050.
14. Gazmuri R.J., Weil M.H., Bisera J., Tang W., Fukui M., McKee D. Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit. Care Med. 24:1996;992-1000.
15. Kern K.B., Hilwig R.W., Rhee K.H., Berg R.A. Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J. Am. Coll. Cardiol. 28:1996;232-240.
16. Teerlink T., Hennekes M., Bussemaker J., Groeneveld J. Simultaneous determination of creatine compounds and adenine nucleotides in myocardial tissue by high-performance liquid chromatography. Anal. Biochem. 214:1993;278-283.
17. Mittra B. Effects of potassium, glucose and insulin therapy on cardiac arrest after myocardial infarction. J. Med. Sci. 7:1968;373-385.
18. Goodwin G.W., Taegtmeyer H. Metabolic recovery of the isolated working rat heart after brief global ischemia. Am. J. Physiol. 267:1994;H462-H470.
19. Apstein C.S., Gravino F.N., Haudenschild C.C. Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Effects on contractile function, diastolic compliance, metabolism, and ultrastructure during ischemia and reperfusion. Circ. Res. 52:1983;515-526.
20. Eberli F.R., Weinberg E.O., Grice W.N., Horowitz G.L., Apstein C.S. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ. Res. 68:1991;466-481.
21. + channels in isolated guinea pig cardiac myocytes. Science. 238:1987;67-70.
22. Oliver M.F., Opie L.H. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet. 343:1994;155-158.
23. Hendrickson S.C., St. Louis J.D., Lowe J.E., Abdel-aleem S.L. Free fatty acid metabolism during myocardial ischemia and reperfusion. Mol. Cell. Biochem. 80:1997;3A-10A.
24. Kudo N., Barr A.J., Barr R.L., Deswai S., Lopaschuk G.D. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-Coa carboxylase. J. Biol. Chem. 270:1995;17513-17520.
25. Doenst T., Richwine R.T., Bray M.S., Goodwin G.W., Frazier O.H., Taegtmeyer H. Insulin improves functional and metabolic recovery of reperfused working rat heart. Ann. Thorac. Surg. 67:1999;1682-1688.
26. Tune J.D., Mallet R.T., Downey H.F. Insulin improves cardiac contractile function and oxygen utilization efficiency during moderate ischemia without compromising myocardial energetics. J. Mol. Cell. Cardiol. 30:1998;2025-2035.
27. King L.M., Opie L.H. Glucose and glycogen utilization in myocardial ischemia - changes in metabolism and consequences for the myocyte. Mol. Cell. Biochem. 180:1998;3-26.
28. Lopaschuk G.D., Spafford M.A., Davies N.J., Wall S.R. Glucose and palmitate oxidation in isolated working rat hearts reperfused following a period of transient global ischemia. Circ. Res. 66:1989;546-553.
29. Runnman E.M., Weiss J.N. Exogenous glucose utilization is superior to glycogenolysis at preserving cardiac function during hypoxia. Circulation. 3:1988;407-414.
30. Lui B., Clanachan A.S., Schulz R., Lopaschuk G.D. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ. Res. 79:1996;940-948.
31. Liu B., El Alaoui-Talibi Z., Clanachan A.S., Schulz R., Lopaschuk G.D. Uncoupling of contractile function from mitochondrial tricarboxylic acid cycle activity and oxygen consumption during reperfusion of ischemic rat hearts. Am. J. Physiol. 270:1996;H72-H80.
32. Broderick T.L., Quinney H.A., Barker C.C., Lopaschuk G.D. The beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation. Circulation. 87:1994;972-981.
33. McCormack J.G., Barr R.L., Wolff A.A., Lopaschuk G.D. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic hearts. Circulation. 93:1996;135-142.
34. Longhus S., Wambolt R.B., Barr R.L., Lopaschuk G.D., Allard M.F. Regulation of myocardial fatty acid oxidation by substrate supply. Am. J. Physiol. 281:2001;H1561-H1567.
35. Xia Y., Zweier J.L. Substrate control of free radial generation from xanthine oxidase in the postischemic heart. J. Biol. Chem. 270:1995;18797-18803.